Microbix Biosystems (TSE:MBX) Shares Cross Below 50-Day Moving Average – What’s Next?

Microbix Biosystems Inc. (TSE:MBX) passed below its 50 day moving average during trading on Monday. The stock has a 50 day moving average of C$0.30 and traded as low as C$0.30. Microbix Biosystems shares last traded at C$0.30, with a volume of 20,000 shares trading hands.

Microbix Biosystems Price Performance

The company has a debt-to-equity ratio of 27.69, a current ratio of 6.89 and a quick ratio of 5.57. The business’s 50 day moving average price is C$0.30 and its 200 day moving average price is C$0.28. The stock has a market capitalization of C$42.46 million, a P/E ratio of -8.61 and a beta of 0.76.

Microbix Biosystems (TSE:MBX) last issued its earnings results on Thursday, August 13th. The company reported C($0.01) earnings per share (EPS) for the quarter. Microbix Biosystems had a negative return on equity of 18.83% and a negative net margin of 31.72%.The company had revenue of C$4.06 million during the quarter. Sell-side analysts forecast that Microbix Biosystems Inc. will post 0.02 EPS for the current year.

Microbix Biosystems Company Profile

Microbix Biosystems Inc creates proprietary biological products for human health, with over 120 skilled employees and revenues of C$ 18.6 million in its last reported fiscal year (2025). It enables the worldwide commercialization of diagnostic assays by making a wide range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs ¿ ) and reference materials (QUANTDx ¿ ) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows.